{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:07:43Z","timestamp":1761541663162,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.cgh.2007.06.009","type":"journal-article","created":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T07:12:27Z","timestamp":1191395547000},"page":"1167-1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Celecoxib Plus Aspirin Versus Naproxen and Lansoprazole Plus Aspirin: A Randomized, Double-Blind, Endoscopic Trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Jay L.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron","family":"Cryer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2007.06.009_bib1","unstructured":"Ansani NT, Fedutes BA, Vogt M, et al. Rheumatologic medication utilization in 2003: prescribing trends and retail sales costs. Poster presented at Annual Scientific Meeting of the American College of Rheumatology\/Association of Rheumatology Health Professionals; October 18, 2004; San Antonio, TX. A correction was published at http:\/\/www.rheumatology.org\/press\/2004\/fedutes_nsaid.asp."},{"key":"10.1016\/j.cgh.2007.06.009_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.2001.21907","article-title":"Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient","volume":"120","author":"Laine","year":"2001","journal-title":"Gastroenterology"},{"issue":"Suppl 6A","key":"10.1016\/j.cgh.2007.06.009_bib3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0002-9343(99)00362-9","article-title":"Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications","volume":"107","author":"Bjorkman","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib4","first-page":"804","article-title":"A metaanalysis of severe upper gastrointestinal complications of nonsteroidal anti-inflammatory drugs","volume":"29","author":"Ofman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2007.06.009_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.162.2.169","article-title":"Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole","volume":"162","author":"Graham","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2007.06.009_bib7","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.amjmed.2005.06.020","article-title":"Aspirin use for the primary prevention of coronary heart disease in older adults","volume":"118","author":"Rodondi","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/pds.983","article-title":"Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among US adults","volume":"14","author":"Paulose-Ram","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.cgh.2007.06.009_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archinte.162.2.193","article-title":"Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease","volume":"162","author":"Brown","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding","volume":"310","author":"Weil","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2007.06.009_bib11","first-page":"562","article-title":"Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies","volume":"52","author":"Garcia Rodriguez","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cgh.2007.06.009_bib12","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.clinthera.2004.10.002","article-title":"Ulcer recurrence in high-risk patients receiving nonsteroidal anti-inflammatory drugs plus low-dose aspirin: results of a post hoc subanalysis","volume":"26","author":"Goldstein","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.cgh.2007.06.009_bib13","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis: VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial\u2014Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2007.06.009_bib15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1365-2036.2006.02912.x","article-title":"The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor","volume":"23","author":"Goldstein","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2007.06.009_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D","volume":"43","author":"Hawkey","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2007.06.009_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0016-5085(99)70334-3","article-title":"A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis: Rofecoxib Osteoarthritis Endoscopy Study Group","volume":"117;","author":"Laine","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.06.009_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2036.2004.02118.x","article-title":"Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib","volume":"20","author":"Goldstein","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2007.06.009_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2036.2003.01691.x","article-title":"Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects","volume":"18","author":"Rordorf","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2007.06.009_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(04)16893-1","article-title":"Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial","volume":"364","author":"Schnitzer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2007.06.009_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.gastro.2004.05.001","article-title":"Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial","volume":"127","author":"Laine","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.06.009_bib22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archinte.164.11.1243","article-title":"Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users","volume":"164","author":"Cox","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2007.06.009_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs: Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs: Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib26","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib27","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"10.1016\/j.cgh.2007.06.009_bib28","first-page":"S33","article-title":"Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs: nice or necessary?","volume":"4","author":"Laine","year":"2004","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.cgh.2007.06.009_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2004.01935.x","article-title":"Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications\u2014review and recommendations based on risk assessment","volume":"19","author":"Chan","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2007.06.009_bib30","first-page":"579","article-title":"A clinician\u2019s guide to the selection of NSAID therapy","volume":"27","author":"Fendrick","year":"2002","journal-title":"Pharmacy and Therapeutics"},{"key":"10.1016\/j.cgh.2007.06.009_bib31","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update\u2014American College of Rheumatology Subcommittee on Osteoarthritis Guidelines","volume":"43","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2007.06.009_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000076554","article-title":"Challenges in managing NSAID-associated gastrointestinal tract injury","volume":"69","author":"Goldstein","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2007.06.009_bib33","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.06.009_bib34","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2007.06.009_bib35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1572-0241.2001.03740.x","article-title":"Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis","volume":"96","author":"Goldstein","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2007.06.009_bib36","first-page":"A-81","article-title":"Effects of concomitant aspirin (81 mg qd) on incidence of gastric and\/or duodenal ulcers in healthy subjects taking celecoxib or naproxen: a randomized, placebo-controlled trial","volume":"130","author":"Goldstein","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.06.009_bib37","first-page":"A174","article-title":"Influence of H pylori (Hp) infection and\/or low dose aspirin (ASA) on gastroduodenal ulceration in patients treated with placebo, celecoxib or NSAIDs","volume":"116","author":"Goldstein","year":"1999","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2007.06.009_bib38","first-page":"A345","article-title":"Valdecoxib is less ulcerogenic than conventional NSAIDs in osteoarthritis (OA) and rheumatoid arthritis (RA) patients with high risk of peptic ulcer disease","volume":"122","author":"Goldstein","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.06.009_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","article-title":"Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users","volume":"12","author":"Cullen","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2007.06.009_bib40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529609010347","article-title":"Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy: a Nordic multicentre study","volume":"31","author":"Ekstrom","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2007.06.009_bib41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(07)60234-7","article-title":"Upper gastrointestinal clinical events and symptoms in the double-blind multinational etoricoxib and diclofenac arthritis long-term (MEDAL) program","volume":"369","author":"Laine","year":"2007","journal-title":"Lancet"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507006258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507006258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:00:10Z","timestamp":1761541210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356507006258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1542356507006258"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2007.06.009","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celecoxib Plus Aspirin Versus Naproxen and Lansoprazole Plus Aspirin: A Randomized, Double-Blind, Endoscopic Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2007.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}